CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure

Cash and cash equivalents of €12.3 million as of June 30, 2026, a 2.4-fold increase compared to December 31, 2025 (€5.1 million), following the €15 million capital increase completed in May.Shareholders’ equity returned to positive territory at €3.0 million (compared to −€4.9 million as of December…